Literature DB >> 23131823

Can nutraceuticals prevent Alzheimer's disease? Potential therapeutic role of a formulation containing shilajit and complex B vitamins.

Carlos Carrasco-Gallardo1, Gonzalo A Farías, Patricio Fuentes, Fernando Crespo, Ricardo B Maccioni.   

Abstract

Alzheimer's disease (AD) is a brain disorder displaying a prevalence and impact in constant expansion. This expansive and epidemic behavior is concerning medical and public opinion while focusing efforts on its prevention and treatment. One important strategy to prevent this brain impairment is based on dietary changes and nutritional supplements, functional foods and nutraceuticals. In this review we discuss the potential contributions of shilajit and complex B vitamins to AD prevention. We analyze the status of biological studies and present data of a clinical trial developed in patients with mild AD. Studies suggest that shilajit and its active principle fulvic acid, as well as a formula of shilajit with B complex vitamins, emerge as novel nutraceutical with potential uses against this brain disorder.
Copyright © 2012 IMSS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23131823     DOI: 10.1016/j.arcmed.2012.10.010

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  7 in total

Review 1.  Neuroinflammation in the pathogenesis of Alzheimer's disease. A rational framework for the search of novel therapeutic approaches.

Authors:  Inelia Morales; Leonardo Guzmán-Martínez; Cristóbal Cerda-Troncoso; Gonzalo A Farías; Ricardo B Maccioni
Journal:  Front Cell Neurosci       Date:  2014-04-22       Impact factor: 5.505

2.  Alzheimer's disease patient groups derived from a multivariate analysis of cognitive test outcomes in the Coalition Against Major Diseases dataset.

Authors:  Inna Tishchenko; Carlos Riveros; Pablo Moscato
Journal:  Future Sci OA       Date:  2016-08-19

Review 3.  Neuroinflammation as a Common Feature of Neurodegenerative Disorders.

Authors:  Leonardo Guzman-Martinez; Ricardo B Maccioni; Víctor Andrade; Leonardo Patricio Navarrete; María Gabriela Pastor; Nicolas Ramos-Escobar
Journal:  Front Pharmacol       Date:  2019-09-12       Impact factor: 5.810

4.  Characterization of Fulvic Acid Beverages by Mineral Profile and Antioxidant Capacity.

Authors:  Monika Swat; Iga Rybicka; Anna Gliszczyńska-Świgło
Journal:  Foods       Date:  2019-11-22

5.  Shilajit potentiates the effect of chemotherapeutic drugs and mitigates metastasis induced liver and kidney damages in osteosarcoma rats.

Authors:  Ebtihaj J Jambi; Fawzia Abdulaziz Alshubaily
Journal:  Saudi J Biol Sci       Date:  2022-07-25       Impact factor: 4.052

Review 6.  Tau oligomers as potential targets for Alzheimer's diagnosis and novel drugs.

Authors:  Leonardo Guzmán-Martinez; Gonzalo A Farías; Ricardo Benjamin Maccioni
Journal:  Front Neurol       Date:  2013-10-28       Impact factor: 4.003

7.  Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization.

Authors:  Antonio Dominguez-Meijide; Eftychia Vasili; Annekatrin König; Maria-Sol Cima-Omori; Alain Ibáñez de Opakua; Andrei Leonov; Sergey Ryazanov; Markus Zweckstetter; Christian Griesinger; Tiago F Outeiro
Journal:  Sci Rep       Date:  2020-07-30       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.